Hytrin (Terazosin Hydrochloride)

Terazosin selectively blocks alpha‑1 adrenergic receptors on vascular smooth muscle and in the prostate. This antagonism prevents norepinephrine‑induced contraction, causing blood vessels to dilate and reducing peripheral resistance, while also relaxing the prostate and bladder neck to ease urinary flow.

The dosage of Hytrin is individualized by the prescribing clinician based on the patient’s condition, response, and tolerability. The prescriber determines the starting dose and any subsequent titration, following local prescribing guidelines and clinical judgment.

Safety data for terazosin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Hytrin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Hytrin belongs to the alpha‑1 blocker class, which lowers blood pressure by vasodilation. Compared with ACE inhibitors, calcium‑channel blockers, or diuretics, it may be chosen when a patient also has urinary symptoms from BPH, but it can cause more orthostatic hypotension and requires careful dose titration.

Hytrin tablets should be stored at room temperature, below 25 °C, in the original packaging. Keep them away from moisture, direct sunlight, and out of reach of children. Do not use if the packaging is damaged or the tablets appear discolored.

Hytrin is taken orally, usually once daily with or without food as directed by a healthcare professional. Patients should swallow the tablet whole with a full glass of water and follow any specific timing instructions provided by their prescriber.

The most serious adverse events include severe hypotension, syncope (fainting), and priapism (prolonged erection). These reactions require immediate medical attention. Patients should be educated to rise slowly from sitting or lying positions and to report any sudden drops in blood pressure.

Hytrin is contraindicated in patients with known hypersensitivity to terazosin or any component of the formulation. Caution is advised for individuals with severe liver disease, uncontrolled orthostatic hypotension, or those taking interacting medications that could cause dangerous blood‑pressure drops.